Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Jaguar Health (JAGX) over the last 10 years, with Q3 2025 value amounting to $479000.0.

  • Jaguar Health's Depreciation & Amortization (CF) rose 105.49% to $479000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 51.98%. This contributed to the annual value of $1.9 million for FY2024, which is 561.35% down from last year.
  • Latest data reveals that Jaguar Health reported Depreciation & Amortization (CF) of $479000.0 as of Q3 2025, which was up 105.49% from $478000.0 recorded in Q2 2025.
  • Jaguar Health's 5-year Depreciation & Amortization (CF) high stood at $558000.0 for Q2 2022, and its period low was $426000.0 during Q1 2022.
  • In the last 5 years, Jaguar Health's Depreciation & Amortization (CF) had a median value of $479000.0 in 2025 and averaged $476263.2.
  • As far as peak fluctuations go, Jaguar Health's Depreciation & Amortization (CF) soared by 2976.74% in 2022, and later plummeted by 1113.32% in 2024.
  • Quarter analysis of 5 years shows Jaguar Health's Depreciation & Amortization (CF) stood at $429000.0 in 2021, then rose by 16.32% to $499000.0 in 2022, then increased by 0.6% to $502000.0 in 2023, then dropped by 4.78% to $478000.0 in 2024, then increased by 0.21% to $479000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $479000.0 for Q3 2025, versus $478000.0 for Q2 2025 and $479000.0 for Q1 2025.